Yousef, M.; Mosa, F.E.S.; Barakat, K.H.; Davies, N.M.; Löbenberg, R.
Indirect Modeling of Post-Prandial Intestinal Lymphatic Uptake of Halofantrine Using PBPK Approaches: Limitations and Implications. Pharmaceutics 2025, 17, 1228.
https://doi.org/10.3390/pharmaceutics17091228
AMA Style
Yousef M, Mosa FES, Barakat KH, Davies NM, Löbenberg R.
Indirect Modeling of Post-Prandial Intestinal Lymphatic Uptake of Halofantrine Using PBPK Approaches: Limitations and Implications. Pharmaceutics. 2025; 17(9):1228.
https://doi.org/10.3390/pharmaceutics17091228
Chicago/Turabian Style
Yousef, Malaz, Farag E. S. Mosa, Khaled H. Barakat, Neal M. Davies, and Raimar Löbenberg.
2025. "Indirect Modeling of Post-Prandial Intestinal Lymphatic Uptake of Halofantrine Using PBPK Approaches: Limitations and Implications" Pharmaceutics 17, no. 9: 1228.
https://doi.org/10.3390/pharmaceutics17091228
APA Style
Yousef, M., Mosa, F. E. S., Barakat, K. H., Davies, N. M., & Löbenberg, R.
(2025). Indirect Modeling of Post-Prandial Intestinal Lymphatic Uptake of Halofantrine Using PBPK Approaches: Limitations and Implications. Pharmaceutics, 17(9), 1228.
https://doi.org/10.3390/pharmaceutics17091228